Residual neuromuscular blockade: A persistent clinical problem

International Anesthesiology Clinics

Volumn 44, Issue 2, 2006, Pages 77-90

  Pino, Richard M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; ATRACURIUM BESILATE; CHOLINESTERASE INHIBITOR; CINCHOCAINE; CISATRACURIUM; LOCAL ANESTHETIC AGENT; MIVACURIUM; MUSCLE RELAXANT AGENT; NEOSTIGMINE; PANCURONIUM; PANCURONIUM BROMIDE; ROCURONIUM; SUXAMETHONIUM; VECURONIUM; NEUROMUSCULAR BLOCKING AGENT;

ANESTHESIA COMPLICATION; DRUG ANTAGONISM; DRUG MONITORING; DRUG SAFETY; HUMAN; MUSCLE TETANIC CONTRACTION; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROPHARMACOLOGY; NONHUMAN; PARALYSIS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RESIDUAL PARALYSIS; REVIEW; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROSTIMULATION; NEUROMUSCULAR SYNAPSE; PATIENT MONITORING; PHYSIOLOGY; POSTOPERATIVE COMPLICATION;

ELECTRIC STIMULATION; HUMANS; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; POSTOPERATIVE COMPLICATIONS;

EID: 33746857805     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200604420-00005     Document Type: Review

References (36)

1. Beecher H, Todd D. A study of the deaths associated with anesthesia and surgery. Am J Surg. l954;140:2-34.
2. Ali HH, Utting JE, Nightingale DA, et al. Quantitative assessment of residualcurarization in humans. Br J Anaesth. 1970;42:802-803.
3. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block. II. Br J Anaesth. 1971;43:478-485.
4. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block. I. Br J Anaesth. 1971;43:473-477.
5. Ali HH, Savarese JJ. Monitoring of neuromuscular function. Anesthesiology. 1976;45:216-249.
6. Savarese JJ, Belmont MR, Hashim MA, et al. Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium. Anesthesiology. 2004;100:835-845.
7. Ali HH, Savarese JJ, Lebowitz PW, et al. Twitch, tetanus and train-of-fours indices of recovery from nondepolarizing neuromuscular blockade. Anesthesiology. 1981;54:294-297.
8. Viby-Mogensen J, Howardy-Hansen P, Chraemmer-Jorgensen B, et al. Posttetanic count (PTC): a new method of evaluating an intensenondepolarizing neuromuscular blockade. Anesthesiology. 1981;55:458-461.
9. Drenck NE, Ueda N, Olsen NV, et al. Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four. Anesthesiology. 1989;70:578-581.
10. Pino RM, Basta SJ. Pharmacology of Neuromuscular Blocking Drugs. 2nd ed. St Louis: Mosby; 1998.
11. Small S, Ali HH, Lennon VA, et al. Anesthesia for an unsuspected Lambert-Eaton myasthenic syndrome with autoantibodies and occult small cell lung carcinoma. Anesthesiology. 1992;76:142-145.
12. Brand J, Cullen D, Wilson NE, et al. Spontaneous recovery from nondepolarizing neuromuscular blockade: correlation between clinical and evoked response. Anesth Analg. 1977;56:55-58.
13. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology. 1997;87:1035-1043.
14. Kopman A, Yee P, Neuman G. Relationship of the train-of-four fade ration to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997;86:761-765.
15. Kopman A, Lawson D. Milliamperage requirements for supramaximal stimulation of the ulnar nerve with surface electrodes. Anesthesiology. 1984;61:83-85.
16. Viby-Mogensen J, Jensen NH, Engbaek J, et al. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology. 1985;63:440-443.
17. Samet A, Capron F, Alia F, et al. Single acceleromyographic train-of-four, 100-Hertz tetanus or double-burst stimulation: which test performs better to detect residual paralysis? Anesthesiology. 2005;102:51-56.
18. Gatke MR, Viby-Mogensen J, Rosenstock C, et al. Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand. 2002;46:207-213.
19. Walts L, Thorpe W, Dillon J. Recurarization-fact or fiction. Anesth Analg. 1971;50:879-884.
20. Viby-Mogensen J, Jorgensen BC, Ording H. Residual curarization in the recovery room. Anesthesiology. 1979;50:539-541.
21. Shorten GD, Merk H, Sieber T. Perioperative train-of-four monitoring and residual curarization. Can J Anaesth. 1995;42:711-715.
22. Brull SJ, Ehrenwerth J, Connelly NR, et al. Assessment of residual curarization using low-current stimulation. Can J Anaesth. 1991;38:164-168.
23. Murphy GS, Szokol JW, Franklin M, et al. Postanesthesia care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium. Anesth Analg. 2004;98:193-200, Table of contents.
24. Debaene B, Plaud B, Dilly MP, et al. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042-1048.
25. Kopman AF, Kopman DJ, Ng J, et al. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function. J Clin Anesth. 2005;17:30-35.
26. Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology. 1993;79:913-918.
27. Ballantyne JC, Chang Y. The impact of choice of muscle relaxant on postoperative recovery time: a retrospective study. Anesth Analg. 1997;85:476-482.
28. Freund PR, Bowdle TA, Posner KL, et al. Cost-effective reduction of neuromuscular-blocking drug expenditures. Anesthesiology. 1997;87:1044-1049.
29. Hayes AH, Mirakhur RK, Breslin DS, et al. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia. 2001;56:312-318.
30. Magorian TT, Lynam DP, Caldwell JE, et al. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from avecuronium-induced neuromuscular blockade? Anesthesiology. 1990;73:410-414.
31. Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology. 2002;96:45-50.
32. Epemolu O, Bom A, Hope F, et al. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology. 2003;99:632-637, Discussion 6A.
33. Gijsenbergh F, Ramael S, Houwing N, et al. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005;103:695-703.
34. Bevan DR, Smith CE, Donati F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology. 1988;69:272-276.
35. Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology. 2003;98:1037-1039.
36. Ali HH. Criteria of adequate clinical recovery from neuromuscular block. Anesthesiology. 2003;98:1278-1280.